Because reversal of multidrug resistance increases chemotoxicity, earl
y detection of low P-glycoprotein expression is clinically relevant fo
r justifying early treatment of those patients that might benefit most
from reversal therapy, We elected to score P-glycoprotein in single t
umor cells, because the gene is rarely amplified, mRNA levels do not n
ecessarily correlate with protein levels, and many normal hematopoieti
c or stroma cells within tumors and leukemic marrows also express P-gl
ycoprotein. We enhanced the ''signal-to-noise'' ratio for detecting lo
w P-glycoprotein levels by a novel complex made by pre-incubating mous
e peroxidase-antiperoxidase, used solely to provide a stable framework
for attaching multiple DTAF-labeled F(ab')(2) fragments of rabbit ant
imouse IgG. We improved specificity by using both C219 and C494, which
are directed against separate internal P-glycoprotein epitopes, We st
andardized staining with two series of negative and positive controls,
in which P-glycoprotein was quantified by immunoblot, and confirmed s
ensitivity by staining a low-expression cell Line and ''mixed'' sample
s containing small numbers of positive cells. We measured P-glycoprote
in by flow cytometry, examining aliquots by differential interference
contrast microscopy to identify malignant cells, in which we confirmed
P-glycoprotein staining by fluorescence microscopy, We detected low P
-glycoprotein expression in clinical samples of leukemic blasts, disti
nguishing them from normal P-glycoprotein expression hematopoietic cel
ls, This assay may be valuable for early diagnosis of low, but potenti
ally important expression of P-glycoprotein, thereby allowing early ap
plication of reversal therapy. (C) 1997 Wiley-Liss, Inc.